(Press-News.org) NEW YORK, NY— June 18, 2025 —The American Thoracic Society Research Program has announced that four researchers have been awarded early-career grants to support research advancing pulmonary, critical care, and sleep medicine. The grants, which are generously sponsored by Johnson & Johnson, total $400,000.
These awards support early-career investigators conducting research aimed at understanding the pathways and pathophysiology of pulmonary vascular disease.
The following researchers received one-year grants of $100,000 each:
Gabriel Altit, MD, of McGill University Health Centre – Research Institute / Montreal Children’s Hospital, for “NORDIC-FU: Neonatal Outcomes Related to Early Discovery of Impaired Cardiac Function at Follow-Up.”
John Park, MD, PhD, of The Regents of the University of California, Los Angeles, for “Emerging Role of LOXL2 in Right Heart Failure due to Pulmonary Hypertension: Novel Druggable Target.”
Michael Smith, MD, of The Regents of the University of California, San Francisco, for “Adaptive Right Ventricular Development in Congenital Heart Disease-Pulmonary Hypertension.”
Bingquiang Wen, PhD, of The Regents of the University of Arizona, for “Identify Mouse Lung Endothelial Cell Specific DNA Regulatory Regions in the Foxf1 Enhancer.”
“The American Thoracic Society is proud to announce this year’s recipients of the ATS Early Career Investigator Award in Pulmonary and Vascular Disease,” said Kamran Atabai, MD, chair of the ATS Scientific Grant Review Committee. “These promising investigators represent the future of scientific discovery, and we are committed to supporting their growth and success.”
The Research Program has aligned its grant cycle with the calendar year and is accepting applications for partner grants until July 1, 2025.
The next grant cycle will open in January 2026. Visit our website for more information.
Fund future respiratory health breakthroughs by donating to the ATS Research Program.
END
ATS Research Program announces 2025 Early Career Investigator Awards in Pulmonary Vascular Disease, sponsored by Johnson & Johnson
2025-06-18
ELSE PRESS RELEASES FROM THIS DATE:
FAU awarded $1 million to prevent medication-related harm, falls in older adults
2025-06-18
Researchers from Florida Atlantic University’s Charles E. Schmidt College of Medicine have received a $1 million grant from the Florida Medical Malpractice Joint Underwriting Association to launch a new initiative: the Geriatric Emergency Department Pharmacologic Harm Prevention Project (GREAT PHARM). This program seeks to reduce falls and other adverse drug events (ADEs) among older adults by using pharmacogenomic-guided prescribing, a personalized approach that tailors medications to an individual’s genetic profile.
As America’s population ...
Understanding inflammatory bowel disease: An integrative framework of microbiome, metabolome, and immunological biomarkers
2025-06-18
Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic inflammatory condition of the gastrointestinal tract with a rising global burden. Traditional diagnostic methods like endoscopy are invasive and costly, underscoring the need for non-invasive biomarkers. Recent research highlights the gut microbiome's pivotal role in IBD pathogenesis, alongside metabolomic and immunological dysregulation. This review synthesizes current knowledge on these biomarkers, proposing an integrative model ...
Astronomers capture most detailed thousand-color image of a galaxy
2025-06-18
Astronomers have created a galactic masterpiece: an ultra-detailed image that reveals previously unseen features in the Sculptor Galaxy. Using the European Southern Observatory’s Very Large Telescope (ESO’s VLT), they observed this nearby galaxy in thousands of colours simultaneously. By capturing vast amounts of data at every single location, they created a galaxy-wide snapshot of the lives of stars within Sculptor.
"Galaxies are incredibly complex systems that we are still struggling to understand," says ESO researcher Enrico Congiu, who led a new Astronomy & Astrophysics study on Sculptor. Reaching ...
Ear wax as a possible screening medium for Parkinson’s disease
2025-06-18
Most treatments for Parkinson’s disease (PD) only slow disease progression. Early intervention for the neurological disease that worsens over time is therefore critical to optimize care, but that requires early diagnosis. Current tests, like clinical rating scales and neural imaging, can be subjective and costly. Now, researchers in ACS’ Analytical Chemistry report the initial development of a system that inexpensively screens for PD from the odors in a person’s ear wax.
Previous research has ...
Credit scores of corporate executives may reveal their decisions
2025-06-18
COLUMBUS, Ohio – The personal credit scores of top-level corporate executives can help explain their decision making in the corporate environment, at least when it involves evaluating risk, a new study suggests.
Researchers at The Ohio State University conducted an experiment with a national sample of high-level executives and found that those with subprime credit scores tended to be “yes persons” – even when it was counterproductive.
In contrast, executives with prime ...
Neuroscientist explores ways to reduce seizures in children
2025-06-18
Humans have tens of thousands of genes, many of which produce proteins essential to basic bodily functions. The KCNT1 gene, for example, codes for a protein that maintains normal electrical activity in the brain and helps neurons communicate.
But genes don’t always function perfectly.
For many people, a mutation of the KCNT1 gene causes no symptoms. For others, it can lead to dysfunction of neuronal activity causing learning disabilities, difficulty communicating, and a lifetime of treatment-resistant seizures.
Epileptic disorders caused by mutations in KCNT1 affect ...
Salk Institute scientist Deepshika Ramanan named Rita Allen Foundation Scholar
2025-06-18
LA JOLLA (June 18, 2025)—Salk Assistant Professor Deepshika Ramanan has been named a Rita Allen Foundation Scholar, a distinction given to early-career leaders in the biomedical sciences whose research holds exceptional promise for revealing new pathways to advance human health.
"Shika’s exceptional talent, determination, collaborative spirit, and mentorship skills make her a very deserving recipient of this award,” says Salk President Gerald Joyce. “Her bold approach to important but underappreciated topics in immunology is likely ...
Many species are declining in the Wadden Sea, only a few are thriving
2025-06-18
In a unique collaboration between the University of Groningen and the Carl von Ossietzky Universität Oldenburg, researchers studied population trends across 3,058 populations of various species throughout the entire Wadden Sea. Twenty-four per cent of the populations showed a significant decline in size, and this trend is occurring simultaneously across various groups. Only fourteen per cent of the populations showed an increase in size. These findings were published in the journal Global Change Biology on June ...
Fallouh Healthcare wins funding to develop device providing early diagnosis of cardiac tamponade
2025-06-18
Birmingham-based Fallouh Healthcare has been awarded a grant of £305,050 from Innovate UK as part of the Eureka Eurostar programme to finalise a prototype of PerDeCT™, working alongside their Austrian partner the Medizinische Universität Wien, which aims to be the first device for monitoring cardiac function and early diagnosis of cardiac tamponade, a life-threatening complication after heart surgery.
Although cardiac surgery is safe, cardiac tamponade can come on quickly – usually after the patient has left theatre, and typically late at night when the patient is in intensive care.
It is caused by the accumulation ...
Can enzymes from fungi be used to extract plant components for biofuels and bioplastics?
2025-06-18
Plant cell wall components such as cellulose are abundant sources of carbohydrates that are widely used in biofuels and bioproducts; however, extraction of these components from plant biomass is relatively difficult due to their complexity. In research in FEBS Open Bio, investigators have found that a combination of fungal enzymes can efficiently degrade plant biomass to allow for extraction.
The enzymes are called cellobiose dehydrogenase (CDH) and lytic polysaccharide monooxygenase (LPMO). LPMO and CDH operate together to enhance the degradation ...